The Aberdeen Area Senior Center, 1303 Seventh Ave. S.E., is holding a blood pressure and blood sugar clinic on Tuesday from 10:30 to 11:30 a.m. This clinic is sponsored by Manor Care Health Services, which will have staff members present….
Novo Nordisk’s liraglutide phase-3 trial indicates blood sugar control for type-2 diabtetes (PharmaBiz)
Novo Nordisk’s Liraglutide, a once-daily human GLP-1 analogue, that underwent phase-III study, has proved sustained improvements in blood sugar control in patients with early type-2 diabetes.
Blood Sugar Control With Early Type 2 Diabetes Patients – Data From One-year Liraglutide Phase 3 Study Published In … (Medical News Today)
Data from a 52-week phase 3 study (LEAD 3) of liraglutide, a once-daily human GLP-1 analogue, were published today by The Lancet. The study showed that liraglutide, when taken alone, produces statistically significant and sustained improvements in blood sugar control in patients with early type 2 diabetes, as compared with glimepiride, a widely used oral antidiabetic drug.
CHIP begins Sept. 26 (Lebanon Express)
The Coronary Health Improvement Program, or CHIP, will begin at Lebanon Samaritan Community Hospital on Sept. 26. The class is aimed at teaching healthy lifestyle choices that can help lower blood pressure, blood sugar, and increase overall health.
Comments on this entry are closed.